British Gynaecological Cancer Society and British Menopause Society guidelines: Management of menopausal symptoms following treatment of gynaecological cancer
These guidelines have been developed jointly by the British Gynaecological Cancer Society and British Menopause Society to provide information for all healthcare professionals managing women treated for gynaecological cancer. Menopausal symptoms can have a significant impact on quality of life for women. Cancer therapies, including surgery, pelvic radiotherapy, chemotherapy and endocrine therapy, can all affect ovarian function. The benefits and risks of using hormone replacement therapy are considered by cancer type with guidance on the type of HRT and optimal time of commencement after cancer treatment. Vaginal estrogens can be very effective for improving urogenital symptoms and are safe for the majority of women, including those for whom systemic HRT is contraindicated with rare exceptions. Alternative options to HRT are reviewed including pharmacological and non-pharmacological approaches.
Authors
- Sarah L. Gray (ORCID: https://orcid.org/0000-0002-7800-8462)
- Kristyn Manley (ORCID: https://orcid.org/0000-0001-8415-7758)
- Andreia Fernandes (ORCID: https://orcid.org/0000-0002-6927-0119)
- Katharine Edey
- Jenifer Sassarini (ORCID: https://orcid.org/0000-0001-8173-3633)
- Andrew Phillips (ORCID: https://orcid.org/0000-0003-0952-6810)
- Ranjit Manchanda (ORCID: https://orcid.org/0000-0003-3381-5057)
- Alison Richardson (ORCID: https://orcid.org/0000-0003-3127-5755)
- Alexandra Taylor (ORCID: https://orcid.org/0000-0001-8100-5388)
- Holly Baker‐Rand (ORCID: https://orcid.org/0009-0005-9301-6929)
- Rebecca Bowen (ORCID: https://orcid.org/0000-0002-1169-6125)
- Sadaf Ghaem‐Maghami (ORCID: https://orcid.org/0000-0002-7369-5080)
- Jo Morrison (ORCID: https://orcid.org/0000-0003-0000-520X)
- Melanie C. Davies (ORCID: https://orcid.org/0000-0001-6907-5527)
- Nithya Ratnavelu (ORCID: https://orcid.org/0000-0002-6445-3020)
- Shibani Nicum (ORCID: https://orcid.org/0000-0003-1125-405X)
- Edward G. Hughes
- K. Clément
- Anna Hudson (ORCID: https://orcid.org/0000-0002-5668-6668)
- Timothy Hillard
- Nana Gomes
Institutions
- University of London (GB)
- University College Hospital (GB)
- University College London Hospitals NHS Foundation Trust (GB)
- Institute of Cancer Research (GB)
- Queen Mary University of London (GB)
- Barts Health NHS Trust (GB)
- University of Exeter (GB)
- Royal Devon & Exeter NHS Foundation Trust (GB)
- NHS Greater Glasgow and Clyde (GB)
- University Hospitals Bristol NHS Foundation Trust (GB)
- Musgrove Park Hospital (GB)
- Poole Hospital (GB)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Ovarian Cancer Action (GB)
- Gateshead Health NHS Foundation Trust (GB)
- Royal Marsden Hospital (GB)
- University Hospitals of Derby and Burton NHS Foundation Trust (GB)
- Royal United Hospital Bath NHS Trust (GB)
- University Hospitals Dorset NHS Foundation Trust
- University College London (GB)
- Imperial College London (GB)
- University of Bath (GB)
Publication Details
- Journal
- Post Reproductive Health
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1177/20533691241286666
- Citations
- 16
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 9.32